These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 28783520)

  • 1. Comments on "Malondialdehyde: A novel predictive biomarker for post-stroke depression".
    Jouyban A; Khoubnasabjafari M
    J Affect Disord; 2018 Jan; 225():52-53. PubMed ID: 28783520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Malondialdehyde: A novel predictive biomarker for post-stroke depression-Methodological issues.
    Ashrafi-Asgarabad A; Safiri S
    J Affect Disord; 2018 Feb; 227():847-848. PubMed ID: 29689699
    [No Abstract]   [Full Text] [Related]  

  • 3. Prevalence of post-stroke depression in an Irish sample and its relationship with disability and outcome following inpatient rehabilitation.
    Cassidy E; O'Connor R; O'Keane V
    Disabil Rehabil; 2004 Jan; 26(2):71-7. PubMed ID: 14668142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The serum interleukin-18 is a potential marker for development of post-stroke depression.
    Yang L; Zhang Z; Sun D; Xu Z; Zhang X; Li L
    Neurol Res; 2010 May; 32(4):340-6. PubMed ID: 20482998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High serum levels of malondialdehyde and antioxidant enzymes are associated with post-stroke anxiety.
    Liu Z; Cai Y; Zhang X; Zhu Z; He J
    Neurol Sci; 2018 Jun; 39(6):999-1007. PubMed ID: 29511963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum biomarkers predictive of depressive episodes in panic disorder.
    Gottschalk MG; Cooper JD; Chan MK; Bot M; Penninx BW; Bahn S
    J Psychiatr Res; 2016 Feb; 73():53-62. PubMed ID: 26687614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Post-stroke depression.
    Gupta A; Pansari K; Shetty H
    Int J Clin Pract; 2002 Sep; 56(7):531-7. PubMed ID: 12296616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and predictors of post-stroke mood disorders: A meta-analysis and meta-regression of depression, anxiety and adjustment disorder.
    Mitchell AJ; Sheth B; Gill J; Yadegarfar M; Stubbs B; Yadegarfar M; Meader N
    Gen Hosp Psychiatry; 2017 Jul; 47():48-60. PubMed ID: 28807138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Towards a multi protein and mRNA expression of biological predictive and distinguish model for post stroke depression.
    Yue Y; Jiang H; Liu R; Yin Y; Zhang Y; Liang J; Li S; Wang J; Lu J; Geng D; Wu A; Yuan Y
    Oncotarget; 2016 Aug; 7(34):54329-54338. PubMed ID: 27527872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Poststroke Depressive Symptoms Are Associated With Increased Oxidative Deoxyribonucleic Acid Damage.
    Chen CY; Chen CL; Yang YH; Ho CH; Tseng WC
    J Neuropsychiatry Clin Neurosci; 2018; 30(2):139-144. PubMed ID: 29366374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of self-efficacy, pre-stroke depression and perceived social support on self-reported depressive symptoms during stroke rehabilitation.
    Lewin A; Jöbges M; Werheid K
    Neuropsychol Rehabil; 2013; 23(4):546-62. PubMed ID: 23656456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Major depressive disorder: insight into candidate cerebrospinal fluid protein biomarkers from proteomics studies.
    Al Shweiki MR; Oeckl P; Steinacker P; Hengerer B; Schönfeldt-Lecuona C; Otto M
    Expert Rev Proteomics; 2017 Jun; 14(6):499-514. PubMed ID: 28562112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. S100B Serum Levels Predict Treatment Response in Patients with Melancholic Depression.
    Ambrée O; Bergink V; Grosse L; Alferink J; Drexhage HA; Rothermundt M; Arolt V; Birkenhäger TK
    Int J Neuropsychopharmacol; 2015 Sep; 19(3):pyv103. PubMed ID: 26364276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Vascular depression--a new concise concept?].
    Wetterling T
    Fortschr Neurol Psychiatr; 1999 Jul; 67(7):327-35. PubMed ID: 10443343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcranial direct current stimulation for the treatment of post-stroke depression: results from a randomised, sham-controlled, double-blinded trial.
    Valiengo LC; Goulart AC; de Oliveira JF; Benseñor IM; Lotufo PA; Brunoni AR
    J Neurol Neurosurg Psychiatry; 2017 Feb; 88(2):170-175. PubMed ID: 27815324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical study on depressive state following stroke].
    Kikumoto O
    Seishin Shinkeigaku Zasshi; 1990; 92(7):411-34. PubMed ID: 2236345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The sensitivity of somatic symptoms in post-stroke depression: a discriminant analytic approach.
    de Coster L; Leentjens AF; Lodder J; Verhey FR
    Int J Geriatr Psychiatry; 2005 Apr; 20(4):358-62. PubMed ID: 15799083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Novel Urinary Metabolite Signature for Non-invasive Post-stroke Depression Diagnosis.
    Zhang W; Zhang XA
    Cell Biochem Biophys; 2015 Jul; 72(3):661-7. PubMed ID: 27352185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationship between high-sensitivity C-reactive protein at admission and post stroke depression: a 6-month follow-up study.
    Yang RR; Lu BC; Li T; Du YF; Wang X; Jia YX
    Int J Geriatr Psychiatry; 2016 Mar; 31(3):231-9. PubMed ID: 26042821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. imProving Outcomes after STroke clinical pilot trial protocol.
    Hackett ML; Carter G; Crimmins D; Clarke T; Maddock K; Sturm JW
    Int J Stroke; 2010 Feb; 5(1):52-6. PubMed ID: 20088995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.